BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35402616)

  • 61. Pulmonary Large Cell Neuroendocrine Carcinoma.
    Yang L; Fan Y; Lu H
    Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.
    Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E
    Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
    Wu Y; Lai Y; Zhang M; Li Z
    Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.
    Slodkowska J; Zych J; Szturmowicz M; Demkow U; Rowinska-Zakrzewska E; Roszkowski-Sliz K
    Int J Biol Markers; 2005; 20(4):217-26. PubMed ID: 16398403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).
    Walter RF; Mairinger FD; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Zarogoulidis K; Schmid KW; Zarogoulidis P; Wohlschlaeger J
    Future Oncol; 2015; 11(7):1027-36. PubMed ID: 25804118
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
    Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
    Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of neuro-oncological ventral antigen-1 in small-cell lung cancer and its value in pathological diagnosis.
    Deng S; Liu M; Xiao T; Gao J
    Transl Cancer Res; 2020 Feb; 9(2):1144-1150. PubMed ID: 35117458
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
    Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).
    Messaritakis I; Stoltidis D; Kotsakis A; Dermitzaki EK; Koinis F; Lagoudaki E; Koutsopoulos A; Politaki E; Apostolaki S; Souglakos J; Georgoulias V
    Sci Rep; 2017 Mar; 7():45351. PubMed ID: 28349943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.
    Ferencz B; Megyesfalvi Z; Csende K; Fillinger J; Poór V; Lantos A; Pipek O; Sólyom-Tisza A; Rényi-Vámos F; Schelch K; Lang C; Schwendenwein A; Boettiger K; László V; Hoetzenecker K; Döme B; Berta J
    Lung Cancer; 2023 Jul; 181():107263. PubMed ID: 37270937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
    Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
    Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
    Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.
    Shimizu K; Goto Y; Kawabata-Iwakawa R; Ohtaki Y; Nakazawa S; Yokobori T; Obayashi K; Kawatani N; Yajima T; Kaira K; Mogi A; Hirato J; Nishiyama M; Shirabe K
    Ann Thorac Surg; 2019 Jul; 108(1):235-243. PubMed ID: 30910656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.